Sort
50,496 grants matching “lung cancer”
Rapid, Multiplexed Biosensor for Non-Invasive Detection of Gene Mutations and Personalization of Therapy in Non-Small Cell Lung Cancer
$997,685Avni A Argun · Giner, Inc. · R44 · FY2023 · CA
Rapidly boosting innate immunity in the lungs to protect against pneumonia
$997,525Brenton Scott · Pulmotect, Inc · R44 · FY2013 · AI
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
$997,515Valerie Humblet · Collagen Medical, Llc · R44 · FY2016 · CA
Precision microRNA medicine in cancer
$997,500Frank J. Slack · Beth Israel Deaconess Medical Center · R35 · FY2024 · CA
MethylScan for Early Detection of Liver and Lung Cancer
$997,285Xiaohui Ni · Earlydiagnostics, Inc. · R44 · FY2022 · CA
MethylScan for Early Detection of Liver and Lung Cancer
$997,285Xiaohui Ni · Earlydiagnostics, Inc. · R44 · FY2023 · CA
Development of novel therapeutics for cancer cachexia
$997,245Scott Matthew Ebert · Emmyon, Inc. · R44 · FY2024 · CA
ACHIEVING BETTER CANCER DIAGNOSIS (ABCD): Identifying, supporting, and learning from marginalized patients who experience delayed cancer diagnosis
$996,882Gordon David Schiff · Brigham And Women'S Hospital · R18 · FY2022 · HS
Optimization and Validation of an Indicator Cell Assay for Blood-Based Diagnosis of Alzheimer's Disease
$996,801Jennifer Joy Smith · Precyte, Inc. · R44 · FY2018 · AG
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
$996,733Norman E Breslow · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
How do genome alterations cause human lung cancer?
$996,674Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2019 · CA
Systemic regulation of metastasis
$996,660David Charles Lyden · Weill Medical Coll Of Cornell Univ · R35 · FY2022 · CA
CHEMOPREVENTION OF LUNG AND ESOPHAGEAL CANCER
$996,601University Of Minnesota Twin Cities · P01 · FY2001 · CA
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer
$996,270Reuben J Shaw · Salk Institute For Biological Studies · R35 · FY2017 · CA
Optimization and Validation of an indicator cell assay for blood-based diagnosis of lung cancer
$996,232Jennifer Joy Smith · Precyte, Inc. · R44 · FY2018 · CA
Development of TIMP-2 derivatives or strategies as biologic therapies for cancer
$995,769William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
CardioWatch: An Omics-Based Prediction Assay for Cardiac Late Effects ofAcute Radiation
$995,681John B. Tyburski · Nelson Scientific Labs Llc · R44 · FY2023 · AI
Prostate Cancer Studies
$995,563Michael Cook · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
$995,166Alan S. Wayne · Children'S Hospital Of Los Angeles · U01 · FY2022 · AI
Development of Combination Therapies to Delay/Prevent Acquired Drug Resistance
$995,148Pasi A Janne · Dana-Farber Cancer Inst · R35 · FY2024 · CA
Building a Sustainable Indian Tribal Infrastructure for Translational Research
$995,133Carolyn June Strickland · University Of Washington · RC4 · FY2010 · NR
Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic Malignancies
$995,112Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Development of an immunomodulating peptide as a therapy for osteosarcoma in canine and human
$995,100Joshua Alfaro · Pharmain Corporation · R44 · FY2023 · CA
Development of an immunomodulating peptide as a therapy for osteosarcoma in canine and human
$995,099Joshua Alfaro · Pharmain Corporation · R44 · FY2024 · CA
Center for Interventional Oncology
$995,007Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2010 · CA